Subthalamic deep brain stimulation in patients with a previous pallidotomy

Area of Science:

• Neurosurgery
• Neurology
• Medical Technology

Background:

• Subthalamic nucleus deep brain stimulation (STN-DBS) is a common treatment for Parkinson's disease.
• The efficacy of STN-DBS in patients with a history of unilateral pallidotomy is not well-established.
• Previous pallidotomy may influence the outcomes of subsequent STN-DBS.

Purpose of the Study:

• To evaluate the safety and efficacy of STN-DBS in Parkinson's disease patients who previously underwent unilateral pallidotomy.
• To compare the outcomes of STN-DBS in patients with and without prior pallidotomy.
• To identify potential predictors of STN-DBS outcomes in this specific patient group.

Main Methods:

• Retrospective analysis of 10 patients who received STN-DBS after unilateral pallidotomy.
• Comparison with a matched control group of 25 patients who received STN-DBS without prior pallidotomy.
• Assessment of efficacy using off-medication Unified Parkinson's Disease Rating Scale (UPDRS) part III motor scores and UPDRS dyskinesia scores.

Main Results:

• Patients with prior pallidotomy showed a 16.0% improvement in UPDRS motor scores after STN-DBS.
• Control patients without prior pallidotomy showed a 49.9% improvement in UPDRS motor scores (P < 0.001).
• Adverse events in the prior pallidotomy group included dysarthria and balance issues; changes in dyskinesia scores were similar between groups.

Conclusions:

• STN-DBS after pallidotomy resulted in significantly less motor improvement compared to STN-DBS alone.
• Prior pallidotomy may be a negative predictor for STN-DBS outcomes.
• Careful patient selection is crucial for individuals considering STN-DBS with a history of pallidotomy.